Skip to main content
Clinical Trials/JPRN-UMIN000014338
JPRN-UMIN000014338
Completed
未知

Clinical study to examine the efficacy of the intravitreal injection of anti-VEGF antibody (Avastin) for intraocular neovascular disease and macular edema - Clinical study to examine the efficacy of the intravitreal injection of anti-VEGF antibody (Avastin)

Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine0 sites3,000 target enrollmentJune 25, 2014

Overview

Phase
未知
Intervention
Not specified
Conditions
Ophthalmic neovascular disease Diabetic retinopathy Retinal vein occlusion
Sponsor
Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine
Enrollment
3000
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 25, 2014
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) The patient who has difficulty in observation of the fundus for high cataract, corneal clouding 2\) Patient younger than 20 years 3\) The patient who received other study medication or other clinical experimental medicine within three months before this medication start 4\) In addition, the patient who judged an examination responsibility (allotment) doctor to be inappropriate as a subject

Outcomes

Primary Outcomes

Not specified

Similar Trials